Fabhalta (iptacopan)
pCPA File Number:
23066
Negotiation Status:
Under consideration for negotiation
Indication(s):
Paroxysmal nocturnal hemoglobinuria (PNH)
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0851-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable